Community
Products
Complications & Care
Food
Columns
Fitness
Medications
Research
Monitoring
Health Care
Psychology
Legal
Celebrities
Pregnancy
About Us
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Discuss this Topic in the Forum

See What's Inside…
  • Diabetes and Adoption

    Rachel and her husband chose to adopt a baby instead of meeting the challenges of handling a high risk pregnancy and Rachel’s type 1 diabetes at the same time. She shares their thought process and ultimate happy ending about the decision to bring a child into their lives.

  • Chris Matthews Makes Time for Diabetes

    Hosting Hardball on MSNBC and The Chris Matthews Show keep Chris Matthews working long hours. But Matthews got a lesson in priorities and made some life changes when he was diagnosed with type 2.

  • A Chihuahua with Diabetes

    Olivia and her dog both have diabetes and today they comfort and encourage each other through the rigors of dealing with the disease. Plus, find out what it means when your domestic pet is diagnosed with diabetes.

  • Smoking and Diabetes

    Smoking has severe effects on your diabetes and your health. Learn why diabetes and smoking are an especially bad combination and get some tips from the experts on how to quit.

  • Continuous Glucose Monitors

    CGM is a relatively new technology, but the information it provides is invaluable. Find out what CGM offers and whether it could help you.

See the entire table of contents here!

Free Subscription to Diabetes Health Professional

The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.

Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.

Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.

Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.

Learn More About the Professional Subscription

Diabetes Health E-Newsletter

Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.

See an example E-Newsletter

As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!

Email Address:
Area of Interest:
ADVERTISEMENT
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Type 2 Issues Archives
ADVERTISEMENT
Print | Email | Share | Comments (10)

Byetta Dusts Insulin In Year-Long Trial

Linda von Wartburg
Dec 11, 2007

In a recent randomized study, 69 people with type 2 diabetes who were already taking metformin were given either Byetta or Lantus for a full year. When the results were in, Byetta came out ahead on several fronts.

Byetta controlled blood sugar about as well as Lantus; both medicines reduced A1c's by slightly less than a point. But when it came to hypoglycemia, Byetta took the honors: 24.2 percent of the Lantus patients had an low blood sugar episode during the trial, compared to only 8.3 percent of the Byetta group.

Where Byetta really shone was in weight loss. The Byetta patients lost about eight pounds, but the Lantus group gained about two pounds.

With regard to beta cell function, Byetta won out as well. The patients' beta cell health was assessed by measuring their secretion of C-peptide, a byproduct of the body's own insulin output. After the year of treatment, the Byetta group could produce considerably more C-peptide than the Lantus group was able to manage, indicating that the Byetta group's beta cells were in robust health compared to the beta cells of the Lantus group.

Usually patients are started on Byetta at five micrograms twice a day for at least thirty days, but then later upped to ten micrograms twice daily. In this study, the Byetta doses were increased to as much as twenty micrograms three times a day, a dosage that is not yet approved by the FDA.

Source: Lilly Press Release, September 2007


Categories: A1c Test, Byetta, Insulin, Low Blood Sugar (Hypoglycemia), Type 2 Issues, Type 2 Medications


Donate to Diabetes Health
Recommend this :

Average Rating:


You May Also Be Interested In...